HIV-1 strains from a cohort of American subjects reveal the presence of a V2 region extension unique to slow progressors and non-progressors

AIDS

Volumn 14, Issue 3, 2000, Pages 213-223

  Wang, Bin ^c   Spira, Thomas J ^a   Owen, Sherry ^a   Lal, Renu B ^a   Saksena, Nitin K ^b  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b WESTMEAD HOSPITAL   (Australia)

^c NONE

Author keywords

AIDS; env V2; HIV; Long term non progressor; nef; Quasispecies; Viral diversity

Indexed keywords

VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL ARTICLE; CLONE; CONTROLLED STUDY; DISEASE COURSE; GENE AMPLIFICATION; GENETIC ANALYSIS; GLYCOSYLATION; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MOLECULAR EVOLUTION; MONONUCLEAR CELL; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS STRAIN;

AMINO ACID SEQUENCE; BASE SEQUENCE; COHORT STUDIES; DISEASE PROGRESSION; DNA PRIMERS; GENES, NEF; HIV-1; HOMOSEXUALITY, MALE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; SEQUENCE HOMOLOGY, AMINO ACID; VIRUS REPLICATION;

EID: 0034054474     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200002180-00002     Document Type: Article

References (46)

1. 1. Buchbinder SP, Mann D, Louie L, Katz F, Holmberg SD. Genetic cofactors for delayed HIV disease progression. IX International Conference on AIDS. Berlin, June 1993 [abstract 326].
2. 2. Balotta C, Bagnarelli P, Riva C, et al. Comparable biological and molecular determinants in HIV type 1-infected long-term non-progressors and recently infected individuals. AIDS Res Hum Retroviruses 1997, 13:337-341.
3. 3. Cao Y, Qin L, Zhang L, Safrit J, Ho DD. Virologic and immunologic characterization of long-term survivors of HIV type 1 infection. New Engl J Med. 1995, 332:201-208.
4. 4. Cheng-Mayer C, Seto D, Tateno M, Levy JA. Biological features of HIV-1 that correlate with virulence in the host. Science 1988, 240:80-82.
5. 5. Deacon NJ, Tsykin A, Solomon A, et al. Genomic structure of an attenuated quasispecies of HIV-1 from a blood transfusion donor and recipients. Science 1995, 270:988-991.
6. 6. Delwart EL, Pan H, Sheppard HW, et al. Slower evolution of HIV-1 quasispecies during progression to AIDS. J. Virol 1997, 17;7498-7505.
7. 7. Easterbrook PJ. Non-progression in HIV infection. AIDS 1994, 8:1179-1182.
8. 8. Iversen AKN, Shaper EG, Rodrigo A, et al. Persistence of attenuated rev genes in an HIV-1 infected asymptomatic individual. J Virol 1995, 69:5743-5753.
9. 9. Barker E. CD8+ cell derived anti-human immunodeficiency virus inhibitory factor. J Infect Diseases 1999, 179 (suppl 3):S485-S488.
10. 10. Strabford SA, Skurnick J, Louria D, et al. Lack of infection in HIV exposed individuals is associated with a strong CD8+ cell noncytotoxic anti HIV response. Proc Natl Acad Sci USA 1999, 96:1030-1035.
11. 11. Smith MW, Dean M, Carrington M, et al. Contrasting genetic influences of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 1997; 227:959-965.
12. 12. Pantaleo G, Menzo S, Vaccarezza M, et al. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med 1995, 332:209-216.
13. 13. Montefiori DC, Pantaleo G, Fink LM, et al. Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term non-progressors. J Infect Dis 1996, 173:60-67.
14. 14. Haynes BF, Pantaleo G, Fauci AS. Toward an understanding of the correlates of protective immunity to HIV infection. Science 1996, 271:324-328.
15. 15. Berger EA. HIV entry and tropism: the chemokine receptor connection. AIDS 1997, 11 (suppl A):53-59.
16. 16. Saksena NK, Ge YC, Wang B, et al. An HIV-1 infected long-term non-progressor (LTNP): molecular analysis of HIV-1 strains in the vpr and nef genes. Ann Acad Medicine 1996, 25: 848-854.
17. 17. Kirchhoff F, Greenough TC, Brettler DB, Sullivan JL, Desrosiers RC. Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med 1995, 332:228-232.
18. 18. Huang Y, Zhang L, Ho DD. Characterization of nef sequences in long-term survivors of human immunodeficiency virus type 1 infection. J Virol 1995, 69:93-100.
19. 19. Michael NL, Chang G, D'Arcy L. Defective accessory genes in HIV-1 infected LTNP lacking reasonable virus. J Virol 1995, 69:4228-4236.
20. 20. Saksena NK, Ge YC, Wang B, et al. RNA and DNA sequence analysis of the nef gene of HIV type 1 strains from the first HIV type 1-infected long-term nonprogressing mother-child pair. AIDS Res Hum Retroviruses 1997, 13:729-732.
21. 21. Wang B, Ge YC, Palasanthiran P, et al. Gene defects at the C-terminus of the vpr gene of HIV-1 in LTNP mother-child pair: In vivo evolution of vpr quasispecies in blood and plasma. Virology 1996, 223:224-232.
22. 22. Felsenstein J. PHYLIP (Phylogeny Inference Package), version 3.56c. Seattle: University of Washington; 1992.
23. 23. Thompson JD, Higgins DG, and Gibson TJ. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acid Res 1994, 22:4673-4680.
24. 24. Shankarappa R, Gupta P, Learn GH, et al. Evolution of HIV envelope sequences in infected individuals with differing disease progression profiles. Virology 1998, 241:251-259.
25. 25. Myers G, Hahn BH, Mellors JW, et al. Human retroviruses and AIDS. A compilation and analysis of nucleic acid and amino acid sequences. Los Alamos: Theoretical Biology and Biophysics Publishing; 1998.
26. 26. Shioda T, Oka S, Xiu X, et al. In vivo sequence variability of HIV-1 env gp120. Association of V2 extension with slow disease progression. J Virol 1997, 71:4871-4881.
27. 27. Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996, 86:367-377.
28. 28. Lukashov VV, Kuiken CL, Goudsmit J. Intrahost human immunodeficiency virus type 1 evolution is related to length of the immunocompetent period. J Virol 1995, 69:6911-6916.
29. 29. Kestler III HW, Ringler DJ, Mori K, et al. Importance of the nef gene for maintenance of high viral loads and for the development of AIDS. Cell 1991, 65:651-662.
30. 30. Kirchhoff F, Kestler III HW, and Desrosiers RC. Upstream V3 sequences in SIV are selectively deleted in vivo in the absence of an intact nef gene. J Virol 1994, 63:2031-2037.
31. 31. Salvi R, Garbuglia AR, Caro AD, et al. Grossly defective nef gene sequences in a human immunodeficiency virus-1 seropositive LTNP. J Virol 1998, 72:3646-3657.
32. 32. Gibbs JS, Regier DA, Desrosiers RC. Construction and in vitro properties of SIVmac mutants with deletions in the nonessential genes. AIDS Res Hum Retroviruses 1994, 12:1982-1986.
33. 33. Zhang L, Huang Y, Yuan H, Tuttleton S, Ho DD. Genetic characterization of vif, vpr, and vpu sequences from long-term survivors of HIV-1 infection. Virology 1997, 228:340-349.
34. 34. Learmont JL, Geczy AF, Mills J, et al. Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1: A report from the Sydney blood bank cohort. New Engl J Med 1999, 340:17151-17722.
35. 35. Greenough TC, Sullivan JL, Desroisiers RC. Declining CD4 T-cell counts in a person infected with nef-deleted HIV-1. New Engl J Med 1999, 230: 236-237.
36. 36. Saksena NK, Wang B, Ge YC, et al. Region-specific changes, gene duplications, and random deletions in the nef gene from HIV type 1-infected brain tissues and blood of a demented patient. AIDS Res Hum Retroviruses 1997, 13:111-116.
37. 37. Sodora DL, Cohen GH, Eisenberg RJ. Influence of asparagine-linked oligosaccharides on antigenicity, processing and cell surface expression of HSV-1 glycoprotein D. J Virol 1989, 63:5184-5193.
38. 38. Alexander S, Elder JH. Carbohydrate dramatically influences immune reactivity of antisera to viral glycoprotein antigens. Science 1984, 226:1328-1332.
39. 39. Wang B, Jozwiak R, Ge YC, Saksena, NK. A unique, naturally occurring single-amino acid mutation in HIV-1 type-1 V3 loop can discriminate between its cytopathicity and replication in vivo and in vitro. AIDS Res and Hum Retroviruses 1998, 14:1019-1021.
40. 40. Wang B, Ge YC, Jozwiak R, et al. Molecular analyses of human immunodeficiency virus type 1 V3 region quasispecies derived from plasma and peripheral blood mononuclear cells of the first long-term-nonprogressing mother and child pair. J Infect Dis 1997, 175:1510-1015.
41. 41. Wolinsky SM, Korber BTM, Neumann AU, et al. Adaptive evolution of HIV-1 during natural course of infection. Science 1996, 272:637-642.
42. 42. Shioda T, Levy JA, Cheng Mayer C. Macrophage and T-cell line tropism of HIV is determined by specific region of the env gp120 gene. Nature 1991, 349:167-169.
43. 43. Fouchier RA, Groenink M, Kootstra NA, et al. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J Virol 1992, 66:3183-3187.
44. 44. Hwang SS, Boyle TJ, Lyerly HK, Cullen BR. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 1991, 253:71-74.
45. 45. Rizzuto CD, Wyatt R, Hernandez-Ramos N, et al. A conserved HIV-gp120 glycoprotein structure involved in chemokine receptor binding. Science 1998, 280:1949-1953.
46. 46. Wyatt R, Sodroski J. The HIV-1 envelope glycoproteins: fusogens, antigens and immunogens. Science 1998, 280:1884-1888.